Over the last seven decades, applications using members of the Bacillus subtilis group have
emerged in both food processes and crop protection industries. Their ability to form survival …

Covering: 2006 to 2017 Actinomycetes have been, for decades, one of the most important
sources for the discovery of new antibiotics with an important number of drugs and analogs …

Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over
the past several decades. In this review the factors that have been linked to this …

Although biosynthetic gene clusters (BGCs) have been discovered for hundreds of bacterial
metabolites, our knowledge of their diversity remains limited. Here, we used a novel …

Antibiotics have been a cornerstone of innovation in the fields of public health, agriculture,
and medicine. However, recent studies have shed new light on the collateral damage they …

Covering: 2002 to 2020 In their natural environment, fungi must compete for resources. It
has been hypothesized that this competition likely induces the biosynthesis of secondary …

Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and
the community. New antibiotics are needed to combat these bacterial pathogens, but …

Recent developments in next-generation sequencing technologies have brought recognition
of microbial genomes as a rich resource for novel natural product discovery. However …

There is a continuous need for iterative cycles of antibiotic discovery and development to
deal with the selection of resistant pathogens that emerge as therapeutic application of an …

The largely unexplored marine world that presumably harbors the most biodiversity may be
the vastest resource to discover novel 'validated'structures with novel modes of action that …